This week in the world of biotech, things were opening up:
- GSK, the UK Government and The Wellcome Trust are opening a new science park [1], pitching “jobs, jobs, jobs” to constituents, and pitching “open innovation” to potential tenants. But “open innovation” probably doesn’t mean the same thing in biotech as it does in the rest of the world, so don’t hold your breath waiting to see a Creative Commons logo on your Tylenol bottle.
- mdBriefcase, which provides online education to physicians, is opening up a Canadian consumer health website called MedSchoolForYou.com [2], but it has some way to go before it matches U.S. resources like WebMD.
- Finally, even though Congress has passed three health care reform bills out of committee, the question of a follow-on biologics (biosimilars) pathway is still open [3], and will have to be resolved in conference. How long will the data exclusivity period be? Advocates on both sides are still slugging it out [4].
Open up a new browser window and head to the Cross-Border Biotech Blog [5] or the Twitter stream @crossborderbio [6] for more.